about
Personalized characterization of diseases using sample-specific networksDipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancerNetwork-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifenISL1, a novel regulator of CCNB1, CCNB2 and c-MYC genes, promotes gastric cancer cell proliferation and tumor growth.Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma.Identification of potential therapeutic targets for colorectal cancer by bioinformatics analysis.Identification of genes and pathways in nasopharyngeal carcinoma by bioinformatics analysis.SMYD5 Controls Heterochromatin and Chromosome Integrity during Embryonic Stem Cell Differentiation.Identification of the potential crucial genes in invasive ductal carcinoma using bioinformatics analysis.Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.Clinical significance and biological roles of cyclins in gastric cancerUpregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients
P2860
Q28586781-5EBBB388-4F51-4766-A0B7-27BB07EAA07CQ33703293-08BCD1CC-6B77-4A74-9A08-29BFB8DD0E95Q36214336-057C768E-258C-4E99-9BAB-D495D357F5EBQ37392747-46B54EE7-F288-442F-892E-4ECA08A98CFFQ37709125-80CD3BFD-11CC-4233-8F41-61D57A46D2B3Q39011091-4ADDFC95-CCEE-4466-9A82-824658842294Q41858931-4E4A6117-53A6-4C99-8F18-6F3FAD4AF3D8Q47739121-65A8212D-07A6-440F-9AE3-38FA959F7A2FQ50231197-158E5DFE-65BD-453C-A35C-D03FC8460E40Q52716882-A491D380-641C-4938-8A54-8F71761592C9Q57817291-9D8E35DC-4777-45F6-83E1-AFBD707A3979Q58603880-A9B4C5F0-8990-4739-BAB7-05B1939D7FD9
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
CCNB1 is a prognostic biomarker for ER+ breast cancer.
@en
CCNB1 is a prognostic biomarker for ER+ breast cancer.
@nl
type
label
CCNB1 is a prognostic biomarker for ER+ breast cancer.
@en
CCNB1 is a prognostic biomarker for ER+ breast cancer.
@nl
prefLabel
CCNB1 is a prognostic biomarker for ER+ breast cancer.
@en
CCNB1 is a prognostic biomarker for ER+ breast cancer.
@nl
P2093
P1433
P1476
CCNB1 is a prognostic biomarker for ER+ breast cancer.
@en
P2093
Chengru Wang
Wenqing Li
Xianzhi Zou
Zhiqiang Zou
P304
P356
10.1016/J.MEHY.2014.06.013
P577
2014-06-27T00:00:00Z